M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 13.49 USD 0.75%
Market Cap: 969.9m USD

Wall Street
Price Targets

MLTX Price Targets Summary
MoonLake Immunotherapeutics

Wall Street analysts forecast MLTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLTX is 19.22 USD with a low forecast of 2.02 USD and a high forecast of 89.25 USD.

Lowest
Price Target
2.02 USD
85% Downside
Average
Price Target
19.22 USD
42% Upside
Highest
Price Target
89.25 USD
562% Upside
MoonLake Immunotherapeutics Competitors:
Price Targets
DNA
Ginkgo Bioworks Holdings Inc
27% Upside
UTHR
United Therapeutics Corp
1% Upside
6996
Antengene Corporation Ltd
84% Upside
ALXO
ALX Oncology Holdings Inc
105% Upside
ARGX
argenx SE
15% Upside
ORY
Oryzon Genomics SA
135% Upside
KURA
Kura Oncology Inc
199% Upside
GOSS
Gossamer Bio Inc
172% Upside

Revenue
Forecast

Revenue Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLTX's stock price target?
Price Target
19.22 USD

According to Wall Street analysts, the average 1-year price target for MLTX is 19.22 USD with a low forecast of 2.02 USD and a high forecast of 89.25 USD.

Back to Top